Medscape13d
Safety and Efficacy of Combined Long-Acting Beta-Agonists and Inhaled Corticosteroids vs Long-Acting Beta-Agonists Monotherapy for Stable COPD
Background: Current guidelines recommend the use of inhaled corticosteroids (ICSs) added to long-acting β 2-agonists (LABAs) for treatment of symptomatic patients with severe and very severe COPD ...
Medscape8d
The Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome
The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...